0,1
"4.5	
Guidelines for classification and staging systems",
Recommendations,Strength rating
"Do not subject men to prostate-specific antigen (PSA) testing without counselling them on 
the potential risks and benefits.",Strong
"Offer an individualised risk-adapted strategy for early detection to a well-informed man with 
a life-expectancy of at least 10 to 15 years.",Weak
"Offer early PSA testing to well-informed men at elevated risk of having PCa:
• 
men from 50 years of age;
• 
men from 45 years of age and a family history of PCa;
• 
men of African descent from 45 years of age;
• 
men carrying BRCA2 mutations from 40 years of age.",Strong
